- Home
- EZGO vs SLRX Comparison
EZGO vs SLRX Comparison
Compare EZGO & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EZGO
- SLRX
- Stock Information
- Founded
- EZGO 2014
- SLRX N/A
- Country
- EZGO China
- SLRX United States
- Employees
- EZGO N/A
- SLRX N/A
- Industry
- EZGO Motor Vehicles
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- EZGO Consumer Discretionary
- SLRX Health Care
- Exchange
- EZGO Nasdaq
- SLRX Nasdaq
- Market Cap
- EZGO 2.0M
- SLRX 1.8M
- IPO Year
- EZGO 2021
- SLRX N/A
- Fundamental
- Price
- EZGO $0.34
- SLRX $0.92
- Analyst Decision
- EZGO
- SLRX
- Analyst Count
- EZGO 0
- SLRX 0
- Target Price
- EZGO N/A
- SLRX N/A
- AVG Volume (30 Days)
- EZGO 111.2K
- SLRX 3.5M
- Earning Date
- EZGO 01-17-2025
- SLRX 08-08-2025
- Dividend Yield
- EZGO N/A
- SLRX N/A
- EPS Growth
- EZGO N/A
- SLRX N/A
- EPS
- EZGO N/A
- SLRX N/A
- Revenue
- EZGO $21,134,425.00
- SLRX N/A
- Revenue This Year
- EZGO N/A
- SLRX N/A
- Revenue Next Year
- EZGO N/A
- SLRX N/A
- P/E Ratio
- EZGO N/A
- SLRX N/A
- Revenue Growth
- EZGO 32.75
- SLRX N/A
- 52 Week Low
- EZGO $0.29
- SLRX $0.45
- 52 Week High
- EZGO $1.91
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- EZGO 46.88
- SLRX 55.98
- Support Level
- EZGO $0.31
- SLRX $0.61
- Resistance Level
- EZGO $0.35
- SLRX $1.33
- Average True Range (ATR)
- EZGO 0.02
- SLRX 0.14
- MACD
- EZGO -0.00
- SLRX 0.03
- Stochastic Oscillator
- EZGO 46.97
- SLRX 52.84
About EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.